Pre-Market Analysis on MGIC Investment, Ultra Petroleum, Opko Health, and Accuray

LONDON, March 15, 2013 /PRNewswire/ --

It was a perfect 10 for the Dow Jones on Thursday as the benchmark index finished higher for a tenth successive trading session. Once again, market sentiment was lifted by better-than-expected economic data. A report from the Labor Department showed that initial jobless claims fell unexpectedly for the week ended March 9th. With stocks continuing to rally, it is not just investors who are pouring money into equity markets but also company insiders. Several companies, including MGIC Investment Corp. (NYSE: MTG), Ultra Petroleum Corp. (NYSE: UPL), Opko Health Inc. (NYSE: OPK), and Accuray Incorporated (NASDAQ: ARAY) have seen insider buying recently. StockCall has posted free technical research on MTG, UPL, OPK, and ARAY which can be downloaded upon sign up at

Mortgage insurer MGIC Investment Corp. has seen significant insider buying this month. The company reported six major insider buys earlier this month, including from its CFO and CEO. J. Michael Lauer, the company's CFO and Executive Vice President, bought a total of 100,000 shares earlier this month in two separate transactions. Curt Culver, the company's Chairman and CEO, bought 50,000 shares on March 7th. MGIC Investment Corp. shares ended lower on Thursday. The stock finished 1.20% lower at $4.95 on volume of 17.78 million. The company's shares currently have a beta of 3.38. Sign up and read the complimentary report on MTG at

Marshall Smith, CFO and Senior Vice President at Ultra Petroleum Corp., recently bought 1,000 shares of the company's common stock. Smith bought the shares at $19.01 per share. Ultra Petroleum Corp. shares have had an excellent run over the last three trading sessions, gaining more than 10%. On Thursday, the stock rose 6.14% to finish at $20.75 on above average volume of 7.18 million. The Independent Oil & Gas company's shares have outperformed the broad market in 2013, gaining more than 14%. The stock currently has a beta of 0.85. The free report on UPL can be downloaded by signing up now at

Opko Health Inc. Chairman and CEO Phillip Frost has bought shares of the company's stock in several transactions since the start of this month. On March 12, Frost bought 37,100 shares of Opko Health Inc. common stock. A day before, he bought 23,500 shares of Opko Health Inc. common stock. The company's shares ended marginally higher in Thursday's session. The stock closed 0.40% higher at $7.54 on volume of 1.74 million. The stock is currently trading close to its 52-week high of $7.59. Year-to-date, Opko Health's shares have gained more than 56%. Free report on OPK can be accessed by registering at

Dennis Winger, Independent Director at Accuray Incorporated, recently bought 20,000 shares of the company's common stock at $4.30 per share. Winger made a total investment of $85,938. On Thursday, Accuray's shares rose sharply. The stock ended the day 3.53% higher at $4.69 on volume of 1.62 million after hitting an intra-day high of $4.72. Despite the sharp rise in yesterday's session, the company's shares have fallen more than 27% this year, even as the broad market has rallied. The stock currently has a beta of 1.06. Register with StockCall and download the research on ARAY for free at

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at  


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here